Pre-ablation lymphocyte monocyte ratio per unit increase [HR 0.77, 95%CI 0.66–0.90, P = 0.001], MELD score [HR 1.06, 95%CI 1.02–1.11, P = 0.002], Log2 AFP [HR 1.11, 95%CI 1.033–1.2, P = 0.005], tumor number [HR 1.29, 95%CI 1.078–1.53, P = 0.005] and tumor size [HR 1.25, 95%CI 1.043–1.51, P = 0.016] were independent prognostic factors for DFS (Fig. 5). Here, AFP is linked to neoplasm.